5Ostrowsky B, Steinberg JT, Farr B, et al. Reality check : should we try to detect and isolate vancomycin resistant enterococci patients [ J ]. Infect Control Hosp Epidemiol, 2001, 22(2) :116-119.
6Shlaes DM , Gerding DN , John JF Jr , et al. Society for healthcare epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance : guidelines for the prevention of antimicrobial resistance in hospitals [ J ]. Infect Control Hosp Epidemiol, 1997, 18(4) :275-291.
7Fridkin SK, Lawton R, Edwards JR, et al. Monitoring antimicrobial use and resistance: comparison with a notional benchmark on reducing vancomyein use and vancomyein-resistant entcrococci [ J]. Emerg Infect Dis, 2002, 8 (7): 702-707.
8Erbay H, Yalcin AN, Serin S, et al. Nosocomial infections in intensive care unite in a Turkish university hospital: a 2- year survey [ J]. Intensive Care Med, 2003, 29 (9) : 1482-1488.
9Vincent JL, Bihari D J, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Resuits of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory committee [J]. JAMA, 1995, 274(8) :639-644. .
10Richards M J, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System [see comments] [J]. Crit Care Med, 1999, 27(5) :887- 892.
